Dogwood Therapeutics DWTX Total Liabilities
Total Liabilities at other companies
Other financials
Where this comes from
Reported directly by Dogwood Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:Liabilities.
The official record: Dogwood Therapeutics’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →
Ask your AI about Dogwood Therapeutics's total liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Dogwood Therapeutics's total liabilities?
- Dogwood Therapeutics (DWTX) reported total liabilities of $14.58M in Q1 2026.
- How has Dogwood Therapeutics's total liabilities changed year-over-year?
- Dogwood Therapeutics's total liabilities increased by 2.5% year-over-year, from $14.24M to $14.58M.
- What is the long-term trend for Dogwood Therapeutics's total liabilities?
- Over 5 years (2020 to 2025), Dogwood Therapeutics's total liabilities has grown at a 58.4% compound annual growth rate (CAGR), from $1.53M to $15.27M.
- What does total liabilities mean?
- The sum of all current and non-current obligations — everything the company owes to creditors, employees, governments, and other stakeholders.